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1. INTRODUCTION {#hed26280-sec-0005}
===============

Coronavirus disease 2019 (COVID‐19) has rapidly evolved into a pandemic since the first report emerged from China in December 2019.[^1^](#hed26280-bib-0001){ref-type="ref"} With the number of cases rising globally at an exponential rate and with over 10% of these requiring intensive care unit (ICU) admission, demand for critical care increasingly threatens to exceed capacity even among the world\'s most advanced economies.[^2^](#hed26280-bib-0002){ref-type="ref"} At present, supportive treatment forms the basis of therapy, with trials currently ongoing to unearth the optimal medicinal treatment regimen and vaccine. Tracheotomy, through its ability to wean patients off ventilation, can shorten the ICU length of stay and in doing so increase ICU bed capacity; crucial for saving lives at a population level.[3](#hed26280-bib-0003){ref-type="ref"}, [4](#hed26280-bib-0004){ref-type="ref"} Median ICU stay for COVID‐19 patients varies widely between countries ranging between 4 and over 20 days.[^5^](#hed26280-bib-0005){ref-type="ref"}

Tracheotomy constitutes an aerosol generating procedure (AGP), thus potentially exposing the operating surgeon and operating room (OR) team to respiratory droplets from the SARS‐CoV‐2 infected patient.[^6^](#hed26280-bib-0006){ref-type="ref"} With this added risk in mind it is vital that the potential benefits of a reduced ICU stay associated with performing a tracheotomy are balanced against the risks to health care professionals. Despite a number of authors having already published guidelines to minimize risks to health care personnel when performing tracheotomy in the COVID‐19 positive patient,[7](#hed26280-bib-0007){ref-type="ref"}, [8](#hed26280-bib-0008){ref-type="ref"}, [9](#hed26280-bib-0009){ref-type="ref"}, [10](#hed26280-bib-0010){ref-type="ref"}, [11](#hed26280-bib-0011){ref-type="ref"} there is currently a paucity of literature on patient selection criteria for this procedure and outcomes data for patients who have undergone tracheotomy in these circumstances. To address this, we present our data from the first 12 COVID‐19 patients that underwent tracheotomy in our institution, and propose parameters to inform patient selection by identifying those patients who may be more likely to benefit from the procedure. Furthermore, we discuss potential predictive factors that may help clinicians identify at an early stage (48 hours postoperatively) those patients who are likely to have a positive outcome post‐tracheotomy, which may facilitate decisions to step‐down patient care and thus improve the availability of critical care resources to those patients that need it most.

2. METHODS {#hed26280-sec-0006}
==========

This was a prospective study of all COVID‐19 patients undergoing tracheotomy (n = 12) in a Head & Neck Unit in the United Kingdom during a 4‐week period (March‐April 2020). Anesthesiological processes and surgical steps pretracheostomy and peritracheostomy insertion were standardized to minimize risk to staff and improve patient safety during this crucial part of the procedure (see [Supplementary Material](#hed26280-supitem-0001){ref-type="supplementary-material"}). Recordings of the patient\'s fraction of inspired oxygen (FiO~2~) and peak end expiratory pressure (PEEP) were obtained for the 24 hours preceding the procedure, and subsequently collected on a daily basis until the patient was either decannulated and discharged from hospital, or died. Fluctuations in these values, which occurred due to patient intervention/movement were removed in order to facilitate calculation of representative averages for these values. The number of days that patients were kept under sedation and number of days taken for decannulation were also recorded.

Following our experience with our first five tracheotomies and in accordance with our local protocol (see [Supplementary Material](#hed26280-supitem-0001){ref-type="supplementary-material"}) and published literature,[7](#hed26280-bib-0007){ref-type="ref"}, [8](#hed26280-bib-0008){ref-type="ref"}, [9](#hed26280-bib-0009){ref-type="ref"}we instituted selection criteria for all subsequent tracheotomies as follows:Patients should ideally be at least 14 days post‐positive swab resultLow oxygen requirements (FiO~2~ ≤ 40%), sustained for at least 24 hoursPatient able to tolerate clamped tube for 1 minute in ICU ("clamp test")Two failed trials of sedation withholding prior to considering tracheotomyPatients that will not require prone ventilation

Correlation between data sets was determined using the "R" statistical software (v3.6.1, © The R Foundation, Vienna, Austria). Data were ranked, and Spearman\'s rank correlation coefficient was calculated to determine association between data sets.

3. RESULTS {#hed26280-sec-0007}
==========

In total, 12 COVID‐19 patients underwent surgical tracheotomy over a 4‐week period (March‐April 2020), of which two died (patients B and C). Patient B had FiO~2~ values ranging between 81% and 90% in the 24 hours before tracheotomy, whilst patient C had their tracheotomy performed 4 days after having a positive swab result. Of the remaining patients that survived, patients D and E took the longest to be decannulated, both of whom had preoperative FiO~2~ values ≥50%, as well as high PEEP values (Table [1](#hed26280-tbl-0001){ref-type="table"}).

###### 

Summary table outlining patient demographics, comorbidities, ventilatory requirements, and patient outcomes

  Patient   Age   Comorbidities                                              FiO~2~ over 24 hours pre‐op   PEEP over 24 hours pre‐op   Postoperative complications   Current status                                               Days followed up
  --------- ----- ---------------------------------------------------------- ----------------------------- --------------------------- ----------------------------- ------------------------------------------------------------ ------------------
  A         51    Type 2 diabetes, hypertension                              41‐50                         5                           None                          Discharged 12 days post op                                   12
  B         76    Previous pneumothorax and pleurodesis                      81‐90                         6                           Tube displacement             Deceased 4 days post op                                      4
  C         63    Myocardial infarction \>20 years ago                       31‐40                         8                           None                          Deceased 6 days post op                                      6
  D         60    Type 2 diabetes, hypertension                              51‐60                         10                          Leak                          Postoperative deterioration remains sedated and ventilated   21
  E         61    Nil                                                        71‐80                         9                           Leak                          Eventual decannulation at day 18                             19
  F         54    Lupus, asthma                                              41‐50                         8                           None                          Discharged ITU day 11                                        11
  G         75    Osteoarthritis, hypertension                               31‐40                         5                           None                          Discharged ITU day 13                                        13
  H         61    MI and PCI \<10 years ago, Type 2 diabetes, hypertension   20‐29                         6                           None                          Discharged ITU day 11                                        11
  I         66    PE and MI with stent \< 10 years                           30‐39                         6                           None                          Decannulated day 8                                           8
  J         61    Nil past medical history                                   20‐29                         5                           None                          Discharged ITU day 6                                         6
  K         59    Asthma, under investigation for COPD/fibrosis              40‐49                         8                           None                          Off sedation day 6                                           6
  L         68    Mastectomy and radiotherapy                                40‐49                         8                           None                          Off sedation Day 3                                           3

The data suggest that a patient\'s preoperative status in the 24 hours preceding the procedure may highlight those patients likely to benefit from tracheotomy. Figure [1](#hed26280-fig-0001){ref-type="fig"} illustrates each patient\'s preoperative FiO~2~ concentration and PEEP requirements in the format of a bubble plot, which suggests that an FiO~2~ of ≥50% with a PEEP of ≥8 cm of H~2~O in the 24 hours preceding tracheotomy may be associated with a worse outcome, as the patients that did not fulfill these criteria in the 24 hours preceding tracheotomy either died or had a prolonged wean of ventilation despite the procedure.

![Bubble plot plotting average sustained FiO~2~ in the 24 hours preceding tracheostomy (measured in %[^10^](#hed26280-bib-0010){ref-type="ref"}) and PEEP in cm H~2~O (represented by bubble diameter and number within bubble, respectively). Red line represents the cut off between patients doing well (below it) and poorly (above it) \[Color figure can be viewed at [wileyonlinelibrary.com](http://wileyonlinelibrary.com)\]](HED-9999-na-g001){#hed26280-fig-0001}

Cumulative data suggested that patients requiring an FiO~2~ of ≤50% and PEEP of ≤8 cm of H~2~O in the first 48 hours following tracheotomy tended to have a more favorable outcome compared to those exceeding these values. To examine this in greater depth, the proportion of time for each patient at which the PEEP was ≥8 cm H~2~O and the proportion of time FiO~2~ was ≥50% across all days were calculated regardless of length of follow‐up. From this, the average proportion of time that PEEP was ≥8 cm H~2~O and average proportion of time that FiO~2~ ≥ 50% were calculated, with the patients subsequently ranked accordingly. These steps were then repeated but with only looking at the data for up to day 2 post‐tracheotomy to look for early prognostic indicators (see Figures [S1](#hed26280-supitem-0001){ref-type="supplementary-material"} and [S2](#hed26280-supitem-0002){ref-type="supplementary-material"}). The ranks for both parameters were then plotted on a scatter plot (Figure [2](#hed26280-fig-0002){ref-type="fig"}), which illustrates that rank at day 2 post‐tracheotomy strongly correlates with rank from all days, and therefore with the patient\'s final outcome (*ρ* = 0.955, *P* \< .05).

![Patient rank according to average proportion of time FiO~2~ ≥ 50% and PEEP≥8 cm H~2~O at end of patient follow up (y‐axis) plotted against patient rank according to average proportion of time FiO~2~ ≥ 50% and PEEP ≥ 8 cm H~2~O on day 2 post tracheostomy (x‐axis). A higher rank signifies a higher proportion of time spent above the parameters. Spearman\'s rank correlation (*ρ* = 0.955, *P* \< .05)](HED-9999-na-g002){#hed26280-fig-0002}

4. DISCUSSION {#hed26280-sec-0008}
=============

This is the first report of patient outcomes following tracheotomy in COVID‐19 patients, and on the basis of our institutional experience we propose criteria that offer a pragmatic solution to facilitate patient care whilst minimizing risks to health care workers.

Given the risk that tracheotomy in COVID‐19 patients poses to health care workers through aerosolization of SARS‐CoV‐2 virions, it is paramount that these risks are carefully balanced against potential benefits to patient care. Concerns around infection in COVID‐19 patients stem from previous experience from SARS‐CoV, which posed a particular risk to health care workers as peak viral load tended to occur 7 to 10 days post‐infection.[^10^](#hed26280-bib-0010){ref-type="ref"} In contrast, COVID‐19 patients appear to have the highest viral load at the onset of infection and this subsequently declines over time, which may account for the speed at which this novel coronavirus is spreading within the community.[^11^](#hed26280-bib-0011){ref-type="ref"} Furthermore, although it has been shown that SARS‐CoV‐2 RNA can be detected in patients up to 20 days or longer post‐infection, it is unclear whether this represents patients shedding live virus, or if this reflects shedded virions inactivated by host antibodies.[^11^](#hed26280-bib-0011){ref-type="ref"} In the context of planning a tracheotomy, this has two important implications; first, a positive test does not reflect the degree of infectivity of a patient, and second, on the basis of current data we can draw a cautious degree of reassurance that patients are likely to be less infectious the further away they are from their initial presentation. Thus, we believe that undertaking a tracheotomy at least 14 days following a positive swab result, in conjunction with wearing full personal protective equipment (PPE) and taking all the necessary steps to minimize aerosolization peritracheotomy insertion (see [Supplementary Material](#hed26280-supitem-0001){ref-type="supplementary-material"}) presents a pragmatic solution to minimizing risk to staff. To date, none of the OR staff who have been involved with undertaking tracheotomies in COVID‐19 patients has tested positive for the disease in our institution.

In light of the relative uncertainties that exist in the treatment of patients with COVID‐19, patient selection for tracheotomy will ultimately be refined through experience. The selection criteria proposed in this study (FiO~2~ ≤ 50% and PEEP ≤ 8 cm of H~2~O in the 24 hours prior to the tracheotomy) were derived on the basis of our early experience with the first five COVID‐19 tracheotomies; of which, one survived (patient A), two died (patients B and C) and the remaining two had a prolonged wean off the ventilator (patient D, who was taken off ventilation at day 17 post‐procedure, and patient E, who continues to be on ventilation at the time of writing). Of the four patients who had less favorable outcomes, three had either an FiO~2~ ≥ 50% or a PEEP requirement exceeding 8 cm H~2~O. The "anomaly" was patient C who despite being within an acceptable range for both FiO~2~ and PEEP unfortunately died. In retrospect, this patient probably had their tracheostomy too early at day 4 post‐intubation; it is thus vital that ICU teams liaise closely with surgical teams when identifying potential candidates for tracheotomy, and put forward those patients who have demonstrated improvement in their clinical course.

From this study, two important findings emerge in terms of the prognostic value of ventilation‐related parameters prior to tracheotomy. These are an FiO~2~ requirement ≤50% and PEEP ≤8 cm H~2~O in the 24 hours prior to tracheotomy with all patients exceeding these cut off values either experiencing a prolonged wean and dying or failing to improve and continuing to require ICU support. Satisfying both the FiO~2~ and PEEP criteria is equally important when considering tracheotomy in COVID‐19 patients failing trial(s) of extubation. The case of patient D illustrates why consideration of FiO~2~ requirements alone is not adequate when it comes to COVID‐19 patients. Even if preoperative FiO~2~ requirements remain below the 50% cut off, COVID‐19 patients are unlikely to do well following tracheotomy if their PEEP requirements exceed 8 cm H~2~O. The reason is that the high PEEP dependence makes them less able to tolerate the combination of a reduction in FiO~2~ to 21% during tracheal exposure and the subsequent cessation of ventilation prior to tube exchange, both key recommendation for tracheotomy in COVID‐19 patients.[^12^](#hed26280-bib-0012){ref-type="ref"}

Furthermore, we have demonstrated that there is a correlation (*ρ* = 0.955, *P* \< .05) between the proportion of time patients\' PEEP values are ≤8 cm H~2~O and their FiO~2~ values are ≤50% in the first 48 hours following tracheotomy with the respective values (ventilation requirements) across all days of their stay in critical care. This is of clinical importance because it could potentially permit prognostication through early risk‐stratification; with those patients whose ventilator requirements consistently remain below the described cut off values (ie, FiO~2~ ≤ 50% and PEEP ≤ 8 cm of H~2~O) for the first two postoperative days to represent a subgroup that can potentially be safely stepped down to another clinical area outside the ICU environment at that stage. This has the potential of freeing up intensive care beds as early as day 2 post‐tracheotomy for other patients that need it more. Furthermore, with the emergence of field hospitals to help cope with the increased patient demand from the COVID‐19 pandemic, this could assist in identifying those patients who following tracheotomy are suitable for transfer to such facilities, further enhancing ICU capacity, a precious and limited resource in the fight against COVID‐19.

Prior to concluding, it is important to consider the strengths and limitations of this study. The key limitation relates to the small number of patients (n = 12). Another relates to the novelty of the disease studied meaning that it is likely that further refinements to the proposed criteria will be needed in the future as our understanding of the pathophysiology of COVID‐19 evolves. Finally, only two prognostic parameters were studied. Despite these limitations, this study also features a number of key strengths. It is the first to look into the development of formal selection criteria for tracheotomy in ventilated patients with COVID‐19 and the first to determine early prognostic factors for these patients. Moreover, this has been done in a quantitative manner. By providing actual cut off values for pre‐tracheostomy and post‐tracheotomy ventilatory requirements, it facilitates patient selection, permits risk stratification and in doing so can directly assist clinical decision making and inform policy.

In conclusion, this study presents for the first time measurable patient selection criteria for tracheotomy in COVID‐19 patients, illustrating that a FiO~2~ ≤ 50% and PEEP ≤ 8 cm H~2~O in the 24 hours prior to tracheotomy are useful markers in helping to identify those patients that are most likely to benefit from a tracheotomy. It has also shown that patients that are able to remain below these threshold values in the first 48 hours following tracheotomy are likely to exhibit a favorable outcome and can thus be stepped down from an intensive care setting at that (early) stage, freeing up vital capacity for other critically ill COVID‐19 patients in need of urgent ICU care.

Supporting information
======================

###### 

**Figure S1**. Bubble plot plotting average sustained FiO~2~ in the 24 hours preceding tracheostomy (measured in %^10^) and PEEP in cm H~2~O (represented by bubble diameter and number within bubble, respectively). Red line represents the cut off between patients doing well (below it) and poorly (above it).

###### 

Click here for additional data file.

###### 

**Figure S2**. Patient rank according to average proportion of time FiO~2~ ≥ 50% and PEEP≥8 cm H~2~O at end of patient follow up (*y*‐axis) plotted against patient rank according to average proportion of time FiO~2~ ≥ 50% and PEEP ≥ 8 cm H~2~O on day 2 post tracheostomy (x‐axis). A higher rank signifies a higher proportion of time spent above the parameters. Spearman\'s rank correlation (*ρ* = 0.955, *P* \< .05).

###### 

Click here for additional data file.
